An antibody that defends a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically.
Join our social circle:
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma UK and Celgene Using REOLYSIN® in Combination with Imnovid® or Revlimid® in Patients with Myeloma Read More
Oncolytics Biotech® Inc. Announces 2016 Year-End Results Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration w Myeloma UK and Celgene Using REOLYSIN® [cont'd] https://t.co/jNgmG6UZP6
Oncolytics Biotech® Inc. Collaborators Present Initial Results from REO 019 Study..[cont'd] https://t.co/dFjpBUiufH